Clinical Trials Directory

Trials / Completed

CompletedNCT02495753

Vaginal Cleansing Before Cesarean Delivery to Reduce Infection

Vaginal Cleansing Before Cesarean Delivery to Reduce Infection: A Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
608 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.

Detailed description

Cesarean delivery is the most common surgical procedure performed on women in the US; nearly 1.3 million are performed each year. Postoperative infectious morbidity is the most common complication of cesarean delivery. Post-cesarean infectious morbidity is often the result of indigenous vaginal flora that ascend into the uterus at the time of surgery. Thus, reducing vaginal microbial load may reduce post-cesarean infection. However, results from studies assessing the role of vaginal cleansing prior to cesarean have been mixed. The investigators will perform a randomized controlled clinical trial to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.

Conditions

Interventions

TypeNameDescription
PROCEDUREVaginal CleansingThe vagina will be prepped in two passes with sponge sticks soaked in 1% povidone-iodine solution from a prepackaged sterile pouch.
PROCEDUREAbdominal CleansingThe abdomen will be cleansed using chlorhexidine or betadine according to surgeon's preference prior to cesarean.

Timeline

Start date
2015-08-01
Primary completion
2021-01-01
Completion
2021-04-01
First posted
2015-07-13
Last updated
2021-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02495753. Inclusion in this directory is not an endorsement.